Send the following on WhatsApp
Continue to ChatLong-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A - https://avesis.istanbul.edu.tr/yayin/467e6c43-f2ca-4b1b-8072-a64287b2afd8/long-term-safety-and-efficacy-results-from-the-phase-3b-open-label-multicentre-continuation-study-of-rurioctocog-alfa-pegol-for-prophylaxis-in-previously-treated-patients-with-severe-haemophilia-a